Oxytocin deficiency - a 'new' human disorder?

Affiliations

Comment

Joseph G Verbalis. Nat Rev Endocrinol. 2023 Sep.

. 2023 Sep;19(9):505-506.

doi: 10.1038/s41574-023-00870-z.

¹ Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, DC, USA. verbalis@georgetown.edu.

No abstract available

Comment on

Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M. Atila C, et al. Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13. Lancet Diabetes Endocrinol. 2023. PMID: 37192642 Clinical Trial.

1. Leng, G., Leng, R. I. & Ludwig, M. Oxytocin-a social peptide? Deconstructing the evidence. Phil. Trans. R. Soc. Lond. B 377, 20210055 (2022). - DOI
1. Sailer, C. O. et al. Oxytocin levels in response to pituitary provocation tests in healthy volunteers. Eur. J. Endocrinol. 185, 355–364 (2021). - DOI - PubMed - PMC
1. Atila, C. et al. Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. Lancet Diabetes Endocrinol. 11, 454–464 (2023). - DOI - PubMed
1. Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H. & Jacob, S. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinol. 46, 23–31 (2014). - DOI
1. Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S. & de Wit, H. Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacol. 39, 1654–1663 (2014). - DOI